Skip to main content
. 2016 Aug 27;7(39):63747–63757. doi: 10.18632/oncotarget.11653

Figure 4. Statistically significant decrease of SUVmean after neoadjuvant therapy in the whole patient group (star is indicating an outlier).

Figure 4